Role and mechanistic actions of protein kinase inhibitors as an effective drug target for cancer and COVID.

Narayanan, J; Tamilanban, T; Kumar, P Senthil; Guru, Ajay; Muthupandian, Saravanan; Kathiravan, M K; Arockiaraj, Jesu

Narayanan, J; Tamilanban, T; Kumar, P Senthil; Guru, Ajay; Muthupandian, Saravanan; Kathiravan, M K; Arockiaraj, Jesu.

Affiliation

Narayanan J; Department of Pharmacology, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu, Tamil Nadu, 603203, India.
Tamilanban T; Department of Pharmacology, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu, Tamil Nadu, 603203, India.
Kumar PS; Faculty of Pharmacy, Karpagam Academy of Higher Education, Pollachi Main Road, Eachanari Post, Coimbatore, Tamil Nadu, 641021, India.
Guru A; Department of Conservative Dentistry and Endodontics, Saveetha Dental College and Hospitals, SIMATS, Chennai, Tamil Nadu, 600077, India. ajayguru.sdc@saveetha.com.
Muthupandian S; AMR and Nanomedicine Lab, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, Tamil Nadu, 600077, India. bioinfosaran@gmail.com.
Kathiravan MK; 209, Dr APJ Abdul Kalam Research Lab, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu, Tamil Nadu, 603203, India. drmkkathir@gmail.com.
Arockiaraj J; Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu, Tamil Nadu, 603203, India. jesuaroa@srmist.edu.in.

Arch Microbiol ; 205(6): 238, 2023 May 17.

Article in En | MEDLINE | ID: mdl-37193831

Subject(s)

COVID-19; Neoplasms; Humans; Protein Kinase Inhibitors/pharmacology; Protein Kinase Inhibitors/therapeutic use; SARS-CoV-2; Neoplasms/drug therapy; Cytokines

Key words

COVID; Cancer; Chronic inflammatory response; Cytokines; Protein kinases

Fulltext

XML

PubMed Links

Search on Google